Second edition of the Neuroscience-based Nomenclature launched
At the presidential symposium at the American Psychiatric Association Annual Meeting in San Diego on 20-24 May, NbN taskforce chair and former ECNP president Joseph Zohar launched the second edition of the NbN. The new edition includes 22 new medications, totalling 130 medications. Translations into Spanish, Japanese, Chinese and French are underway.
The second edition accompanies a new child and adolescent version, the NbN-CA, piloted at the ECNP School of Child and Adolescent Neuropsychopharmacology in Venice on 2-7 April 2017. The NbN-CA is being prepared for general release shortly.